NBIPI Calendar

December
Sun Mon Tue Wed Thu Fri Sat
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0

NBIPI Login



To become a registered NBIPI user, please click here to send us your details.

Contact Us

NBIP Ireland
Research Office
121 St Stephens Green
Dublin 2
Ireland

nbipadmin@rcsi.ie
+353 1 402 8651



Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Project Title: Use of 64 row CT angiographic imaging to evaluate the therapeutic efficacy of IGF1 administration after myocardial infarction

 

Host Laboratory: Centre for Research in Vascular Biology, Biosciences Institute, University College Cork, College Road, Cork, Ireland.

 

Research Interests: Apoptosis and Cancer, Cardiovascular Research

 

Technical Expertise: Imaging and Data Analysis, Integration of Imaging Technologies and Methodologies

  

Publications:

Articles:

  • Developing Cell Therapy Techniques for Respiratory Disease: Intratracheal Delivery of Genetically Engineered Stem Cells in a Murine Model of Airway Injury (2009) Leblond AL, Naud P, Forest V, Gourden C, Sagan C, Romefort B, Mathieu E, Delorme B, Collin C, Pagès JC, Sensebé L, Pitard B, Lemarchand P Human Gene Therapy PMID: 19606934 [Epub ahead of print]
  • Cardiac Cell Therapy: Overexpression of Connexin43 in Skeletal Myoblasts and Prevention of Ventricular Arrhythmias (2009) Fernandes S, van Rijen HV, Forest V, Evain S, Leblond AL, Mérot J, Charpentier F, de Bakker JM, Lemarchand P Journal of Cellular and Molecular Medicine PMID: 194 388 11 [Epub ahead of print]

Reviews:

  • Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction (2009) Leblond AL, O’Sullivan J, Caplice N Stem Cells and Cloning: Advances and Applications [In press]
  • Thérapie génique et cellulaire des maladies respiratoires (2007) Leblond AL, Lemarchand P Pneumologie EMC (Elesevier Masson SAS, Paris), 6-000-P-37

Book Chapters:

  • Chapter 12. A key role of angiogenic control in recovery from ischaemic heart disease, in Molecular mechanisms and targeted clinical approaches for the treatment of angiogenic disease (2009) O’Sullivan J, Leblond AL, Caplice N, Springer Publishers [In press]
Abstract Publication and Oral Communications:
  • Stem cell therapy for cystic fibrosis (2007) Leblond AL, Naud P, Désigaux L, Jourdon P, Pitard B, Sagan C, Delorme B, Sensebé L, Lemarchand P Rev Mal Respir 24: 1228
  • Stem cell therapy for cystic fibrosis (2007) Leblond AL, Naud P, Désigaux L, Jourdon P, Pitard B, Sagan C, Delorme B, Sensebé L, Lemarchand P Journées de la Recherche Respiratoire France (Paris)
  • Stem cell therapy for cystic fibrosis (2007) Leblond AL, Naud P, Désigaux L, Jourdon P, Pitard B, Sagan C, Delorme B, Sensebé L, Lemarchand P European Cystic Fibrosis Young Investigator Meeting France (Lille)
  • Stem cell therapy for cystic fibrosis (2007) Leblond A.L., Naud P, Désigaux L, Jourdon P, Pitard B, Sagan C, Delorme B, Sensebé L, Lemarchand P Lung Science Conferences, European Respiratory Society, Sicilia (Taormina)

Posters:

  • Stem cell therapy for cystic fibrosis (2008) Leblond AL, Naud P, Désigaux L, Jourdon P, Pitard B, Sagan C, Delorme B, Sensebé L, Lemarchand P American Thoracic Society International Conference, Canada (Toronto)

Honours and Awards:

  • Scientific Grants, The French Association “Vaincre la Mucoviscidose” (2005-2006, 2008)
  • 3-Year Scholarship, The French Government
  • EuroCare CF Travel Award